Oxurion NV

FSX : TG4

Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness. It focuses on developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.

Information

Sector
Healthcare
Industry
Biotechnology
Type
Common Stock
Country
Belgium

Price

EUR 0.56

Symbol

TG4

Type

Common Stock

Previous Close

:

0.57

52 Week Range

:

0.56 - 14.00

Volume

:

0.00

Average Volume

:

0.00

High

:

0.56

Low

:

0.56

Change

:

-0.01

Percent change (%)

:

-1.75

Disclaimer: Stakeville is a simulation trading game. All trades and stock prices are fictional and do not reflect real-world markets. This game is for entertainment purposes only and does not involve real financial transactions. Read more...